BPC-157 & TB-500Also known as: Body Protection Compound 157, Thymosin Beta-4, BPC-157, TB-500

Mechanism of Action

BPC-157 promotes angiogenesis, cell survival, and tissue regeneration by enhancing blood vessel formation and cytoprotective mechanisms primarily via upregulation of growth factors and modulation of the nitric oxide system. TB-500 primarily acts by regulating actin cytoskeleton dynamics, promoting cellular migration, proliferation, and extracellular matrix remodeling, which enhances tissue repair, cell migration, and reduces inflammation. The combination acts synergistically to accelerate healing and reduce inflammation in muscle, tendon, and connective tissues by targeting separate but complementary pathways involved in tissue regeneration and repair.

Reported Research Benefits

Commonly used in preclinical studies to investigate muscle injury repair, tendon and ligament regeneration, reduced inflammation, enhanced wound healing, nerve regeneration, and improved mobility. The peptides are studied in animal models for sports injuries, trauma recovery, and fibrosis reduction.

Dosing Protocol & Reconstitution

Typically supplied as lyophilized powder to be reconstituted with bacteriostatic water. Dosing in research commonly involves subcutaneous injections near the injury site, with dosages varying widely but frequently around 10–20 mg vials reconstituted for use within 60 days refrigerated. Researchers use peptide calculators to determine precise dosing based on experimental design.

Research Notes

Both peptides have demonstrated safety and efficacy in multiple preclinical models for accelerating tissue regeneration and reducing inflammation without notable toxicity. BPC-157 shows a local and systemic protective effect on gastrointestinal and musculoskeletal systems. TB-500 has a half-life estimated around 2–3 days, enabling sustained biological activity. Combined use potentiates effects on cellular migration and collagen deposition.

Research Summary

This combination pairs BPC-157's tendon and GI healing properties with TB-500's actin-sequestering, anti-inflammatory, and systemic tissue repair effects. The two peptides act on complementary pathways — BPC-157 promotes local angiogenesis and collagen remodeling while TB-500 modulates cell migration and reduces inflammation — creating a synergistic healing profile used in recovery-focused protocols.

Side Effects & Safety

Inherits the side effect profiles of both BPC-157 and TB-500 individually. No direct human trial data for the combination. Risk is theoretical and primarily limited to angiogenic effects. Injection site reactions possible.

Stability & Storage

Refer to research notes

Molecular Data

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22S
Molecular Weight: 1419.5 g/mol
CAS Number: 137525-51-0
IUPAC Name: N/A (complex peptide chain; typically referenced by peptide name)

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157+TB-500+healing+synergy